Marlborough, MA, United States of America

Jeffrey Vessels

USPTO Granted Patents = 11 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 22(Granted Patents)

Location History:

Marlborough, MA (US) (2010 - 2018)
Cambridge, MA (US) (2022)

Company Filing History:

Millennium Pharmaceuticals Limited

patents

4 out of 63

Sunesis Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2010-2025

where 'Filed Patents' based on already Granted Patents

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12421224 - Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors (2025-09-23),

2. 12319679 - Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors (2025-06-03),

3. 12275728 - O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors (2025-04-14),

4. 12180205 - O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors (2024-12-31),

5. 11459324 - O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors (2022-10-04),

6. 11427561 - IRAK4 inhibiting agents (2022-08-30),

7. 9920048 - Substituted pyrimidines for inhibiting Raf kinase activity (2018-03-20),

8. 8802657 - Compounds useful as Raf kinase inhibitors (2014-08-12),

9. 8293752 - Compounds useful as Raf kinase inhibitors (2012-10-23),

10. 7968536 - Heterocyclic compounds useful as RAF kinase inhibitors (2011-06-28),

11. 7674791 - Triazolopyrazines and methods of making and using the same (2010-03-09),

Title: **The Innovations of Inventor Jeffrey Vessels**

Introduction

Jeffrey Vessels, an accomplished inventor based in Marlborough, MA, is known for his significant contributions to the field of pharmaceuticals through his inventive spirit. With a total of eight patents to his name, Vessels has made notable advancements particularly in the area of glycoprotein inhibitors.

Latest Patents

Among his latest innovations are two patents related to O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors. These patents describe compounds which are either represented by specific molecular formulas or their pharmaceutically acceptable salts. These compounds form the basis of pharmaceutical compositions, aimed at advanced applications and methods for their preparation and utilization. The patents detail various variables that contribute to the effectiveness of these inhibitors.

Career Highlights

Jeffrey Vessels has had a dynamic career, having worked with impactful organizations such as Millennium Pharmaceuticals Limited and Sunesis Pharmaceuticals, Inc. His expertise in the pharmaceutical field has made him a significant contributor to various projects that have shaped modern medicine.

Collaborations

During his career, Vessels has collaborated with talented individuals, including Gnanasambandam Kumaravel and Zhili Xin. These partnerships have been instrumental in fostering innovation and enhancing the development of groundbreaking pharmaceutical solutions.

Conclusion

In conclusion, Jeffrey Vessels exemplifies the innovative spirit of inventors in the pharmaceutical industry. With a robust portfolio of patents and collaborations with esteemed colleagues, he continues to pave the way for advancements that could potentially transform treatment options within the realm of medicine. His ongoing contributions are a testament to the impact of dedicated inventors in pushing the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.